News Powered By:
– a collaborative partner.
CenterWatch : December 18, 2017 6:00 am : Bioethics International, Centerwatch, Clinical Intelligence, Global News
Some of the world’s largest pharmaceutical companies have improved the transparency of their clinical trial data disclosures, according to new analysis from Bioethics International, yet many studies for approved drugs still go unreported. Bioethics International’s second Good Pharma Scorecard, published in the online medical journal BMJ Open, found that companies have made “meaningful progress” on […]
The post Good Pharma Scorecard results show continued drive for transparency appeared first on CenterWatch News Online.
CenterWatch : December 11, 2017 2:53 pm : Awards & Advancement, Centerwatch, Certara, Global News
Certara, a global leader in model-informed drug development and regulatory science, announced that Leigh Farrell, PhD, Vice President of Corporate Strategy and Business Development, is presenting the inaugural Certara New Investigator Awards in association with the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT). The presentation will take place today at the Australasian […]
The post Certara introduces New Investigator Awards program in Australia appeared first on CenterWatch News Online.
CenterWatch : December 11, 2017 2:52 pm : Centerwatch, Clinical Intelligence, COMPASS Pathways, Global News, Worldwide Clinical Trials
COMPASS Pathways, a healthcare company dedicated to accelerating patient access to evidence-based innovation in mental health, announced that it is partnering with Worldwide Clinical Trials to conduct a major program of late-stage clinical trials for psilocybin therapy for treatment-resistant depression. Depression is the leading cause of ill-health and disability worldwide, and one of the fastest growing health […]
CenterWatch : December 11, 2017 2:50 pm : Boehringer Ingelheim, Centerwatch, Distributed Bio, Global News, R&D Trends
Distributed Bio, a global leader in computational optimization of fully human monoclonal antibody libraries, is pleased to announce an agreement with Boehringer Ingelheim to license the Distributed Bio SuperHuman Platform for accelerating biotherapeutics discovery across therapeutic areas. “The SuperHuman Platform represents the culmination of a decade of our research in computational library design,” says Jacob […]
The post Distributed Bio, Boehringer Ingelheim announce SuperHuman Platform Transfer appeared first on CenterWatch News Online.